CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

被引：9
|
作者：
Williams, Alexis K. [1 ]
Klein, Melissa D. [2 ]
Martin, Jesse [1 ]
Weck, Karen E. [4 ]
Rossi, Joseph S. [2 ,3 ]
Stouffer, George A. [2 ,3 ]
Lee, Craig R. [1 ,3 ]
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Div Cardiol, Chapel Hill, NC USA
[3] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA
来源：
CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2019年 / 12卷 / 02期
关键词：
cardiovascular diseases; clopidogrel; pharmacogenetics; precision medicine; IMPLEMENTATION;
D O I：
10.1161/CIRCGEN.119.002441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [1] Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
    Lee, Craig R.
    Sriramoju, Vindhya B.
    Cervantes, Alexandra
    Howell, Lucius A.
    Varunok, Nicholas
    Madan, Shivanshu
    Hamrick, Kasey
    Polasek, Melissa J.
    Lee, John Andrew
    Clarke, Megan
    Cicci, Jonathan D.
    Weck, Karen E.
    Stouffer, George A.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (04): : e002069
  • [2] CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
    Beitelshees, Amber L.
    Thomas, Cameron D.
    Empey, Philip E.
    Stouffer, George A.
    Angiolillo, Dominick J.
    Franchi, Francesco
    Tuteja, Sony
    Limdi, Nita A.
    Lee, James C.
    Duarte, Julio D.
    Kreutz, Rolf P.
    Skaar, Todd C.
    Coons, James C.
    Giri, Jay
    McDonough, Caitrin W.
    Rowland, Rachel
    Stevenson, James M.
    Thai, Thuy
    Vesely, Mark R.
    Wellen, Jacob T.
    Johnson, Julie A.
    Winterstein, Almut G.
    Cavallari, Larisa H.
    Lee, Craig R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (04):
  • [3] Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
    Cavallari, Larisa H.
    Lee, Craig R.
    Beitelshees, Amber L.
    Cooper-DeHoff, Rhonda M.
    Duarte, Julio D.
    Voora, Deepak
    Kimmel, Stephen E.
    McDonough, Caitrin W.
    Gong, Yan
    Dave, Chintan V.
    Pratt, Victoria M.
    Alestock, Tameka D.
    Anderson, R. David
    Alsip, Jorge
    Ardati, Amer K.
    Brott, Brigitta C.
    Brown, Lawrence
    Chumnumwat, Supatat
    Clare-Salzler, Michael J.
    Coons, James C.
    Denny, Joshua C.
    Dillon, Chrisly
    Elsey, Amanda R.
    Hamadeh, Issam S.
    Harada, Shuko
    Hillegass, William B.
    Hines, Lindsay
    Horenstein, Richard B.
    Howell, Lucius A.
    Jeng, Linda J. B.
    Kelemen, Mark D.
    Lee, Yee Ming
    Magvanjav, Oyunbileg
    Montasser, May
    Nelson, David R.
    Nutescu, Edith A.
    Nwaba, Devon C.
    Pakyz, Ruth E.
    Palmer, Kathleen
    Peterson, Josh F.
    Pollin, Toni I.
    Quinn, Alison H.
    Robinson, Shawn W.
    Schub, Jamie
    Skaar, Todd C.
    Smith, D. Max
    Sriramoju, Vindhya B.
    Starostik, Petr
    Stys, Tomasz P.
    Stevenson, James M.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (02) : 181 - 191
  • [4] Effect of Gender on Clinical Outcomes in Patients Receiving CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
    Gustafson, Chelsea
    Gower, Megan N.
    Williams, Alexis K.
    Pauley, Eric
    Weck, Karen E.
    Lee, Craig R.
    Stouffer, George A.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (05): : 554 - 556
  • [5] The effect of CYP2C19 genotype-guided antiplatelet therapy on outcomes of selective percutaneous coronary intervention patients: an observational study
    Tan, Kai
    Lian, Zhexun
    Shi, Yan
    Wang, Xiaxia
    Yu, Haichu
    Li, Mengwan
    Tian, Jianhui
    Ge, Yiping
    PERSONALIZED MEDICINE, 2019, 16 (04) : 301 - 312
  • [6] Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention
    J Park, Joshua
    Cabel, Gervacio Y.
    K Cheng, Kevin
    Dang, Jefferson
    K Ardati, Amer
    Han, Jin
    C Lee, James
    PHARMACOGENOMICS, 2024, 25 (07) : 293 - 298
  • [7] CYP2C19 Genotype-Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure
    Tunehag, Kayla R.
    Pearce, Ashton F.
    Fox, Layna P.
    Stouffer, George A.
    Solander, Sten
    Lee, Craig R.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):
  • [8] Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
    Empey, Philip E.
    Stevenson, James M.
    Tuteja, Sony
    Weitzel, Kristin W.
    Angiolillo, Dominick J.
    Beitelshees, Amber L.
    Coons, James C.
    Duarte, Julio D.
    Franchi, Francesco
    Jeng, Linda J. B.
    Johnson, Julie A.
    Kreutz, Rolf P.
    Limdi, Nita A.
    Maloney, Kristin A.
    Obeng, Aniwaa Owusu
    Peterson, Josh F.
    Petry, Natasha
    Pratt, Victoria M.
    Rollini, Fabiana
    Scott, Stuart A.
    Skaar, Todd C.
    Vesely, Mark R.
    Stouffer, George A.
    Wilke, Russell A.
    Cavallari, Larisa H.
    Lee, Craig R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (04) : 664 - 674
  • [9] Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directions
    Klein, Melissa D.
    Lee, Craig R.
    Stouffer, George A.
    PHARMACOGENOMICS, 2018, 19 (13) : 1039 - 1046
  • [10] CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention
    Borse, Mrudula S.
    Dong, Olivia M.
    Polasek, Melissa J.
    Farley, Joel F.
    Stouffer, George A.
    Lee, Craig R.
    PHARMACOGENOMICS, 2017, 18 (12) : 1155 - 1166
12345